Karyopharm Therapeutics (KPTI) Capital Expenditures Growth (1y) (2014 - 2022)
Karyopharm Therapeutics (KPTI) Capital Expenditures Growth (1y) (2014 - 2022) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
- |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
227.76% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Karyopharm Therapeutics |
95.31 Mn |
31.56 Mn |
32.74 Mn |
- |
| Date | Value |
|---|
| Sep 30, 2022 |
680.00% |
| Dec 31, 2021 |
73.95% |
| Dec 31, 2020 |
138.00% |
| Mar 31, 2020 |
-79.59% |
| Dec 31, 2019 |
-95.43% |
| Sep 30, 2019 |
-78.21% |
| Mar 31, 2019 |
-87.17% |
| Dec 31, 2018 |
1,887.27% |
| Dec 31, 2017 |
120.00% |
| Dec 31, 2016 |
-95.05% |
| Jun 30, 2016 |
-98.99% |
| Mar 31, 2016 |
-78.09% |
| Dec 31, 2015 |
410.10% |
| Sep 30, 2015 |
-94.01% |
| Jun 30, 2015 |
83.95% |
| Mar 31, 2015 |
42.40% |
| Dec 31, 2014 |
209.38% |
